Trademark applications and grants for Kite Pharma Inc. Kite Pharma Inc has 140 trademark applications. The latest application filed is for "AMDDEFY"
Patent Application | Date |
---|---|
IMMUNE CELL FUNCTION 20220289815 - 17/690968 Winter; Ruth E. ;   et al. | 2022-09-15 |
TREATMENT USING CHIMERIC RECEPTOR T CELLS INCORPORATING OPTIMIZED POLYFUNCTIONAL T CELLS 20220265721 - 17/736222 Rossi; John M. ;   et al. | 2022-08-25 |
IMMUNOTHERAPIES 20220265719 - 17/675294 Bot; Adrian ;   et al. | 2022-08-25 |
METHODS AND SYSTEMS FOR PERFORMING A PATIENT-SPECIFIC IMMUNOTHERAPY PROCEDURE WITH CHAIN-OF-CUSTODY AND CHAIN-OF-IDENTITY BIOLOGICAL SAMPLE TRACKING 20220249631 - 17/679521 Susarchick; Debra ;   et al. | 2022-08-11 |
T CELL THERAPY 20220221463 - 17/570917 Bot; Adrian I. ;   et al. | 2022-07-14 |
NCAGE Code | 6WJU5 | KITE PHARMA, INC. |
CAGE Code | 6WJU5 | KITE PHARMA, INC. |
SEC | 0001510580 | Kite Pharma, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.